RxDoctor Payments Data

Rohit Puskoor

Internal Medicine · Arlington, TXNPI 1235302548

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 3 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. That places this record below the midpoint for internal medicine clinicians in TX, where the typical reported total is $270.

$231in general payments, 2019–2025

Across 3 payments — averaging $77.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$116
  • Biogen$115
$1,695,235in research payments, 2019–2025

Across 546 payments — averaging $3104.83 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Boehringer Ingelheim International GmbH$500K
  • GSK$454K
  • Madrigal Pharmaceuticals$338K
  • Regeneron$225K
  • Eli Lilly$144K
  • AstraZeneca$32K
  • plus $2K from 2 others

What the payments were for

  • Food & beverage$231100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Lilly USA, LLC2$116
Biogen1$115

How this compares

$231 in reported general payments places this provider in the 45th percentile of 7,675 internal medicine providers in Texas.

See all internal medicine providers in Texas →

Other internal medicine in Arlington

See the full list for Texas →

Where these figures come from

Is this you, or does something look wrong? →